Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    The Locations section has been expanded to display a broad list of study sites across multiple countries and regions, with specific centers listed.
    Difference
    2%
    Check dated 2025-12-23T09:14:48.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:44:38.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added a PubMed auto-fill notice and updated the Revision to v3.3.1; the previous PubMed note Revision: v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-24T14:45:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removed the administrative notice about a lapse in government funding and potential outdated information. The page now displays the study details without the funding-status banner.
    Difference
    0.1%
    Check dated 2025-11-17T07:13:08.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No significant additions or deletions were identified; the page’s core details (title, trial design, interventions, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:20:52.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    2%
    Check dated 2025-10-05T10:23:27.000Z thumbnail image

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.